Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
SOLIFENACIN SANDOZ (Sandoz Pty Ltd)
Product name
SOLIFENACIN SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
153 working days (255)
Active ingredients
solifenacin succinate
Registration type
New generic medicine
Indication
SOLIFENACIN SANDOZ (tablet) is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.